View Post

Tailored Drug Targets Aggressive Breast Cancer

In In The News by Barbara Jacoby

From: insideprecisionmedicine.com Scientists from King’s College London have made a significant breakthrough in the treatment of aggressive breast cancer by developing a tailored drug that exploits the cancer cells’ weaknesses. This innovative approach, published in Clinical Cancer Research and funded by Breast Cancer Now, offers new hope for patients with triple-negative breast cancer, a particularly challenging form of the disease. …

View Post

Immune targets for chemotherapy-resistant breast cancers identified

In In The News by Barbara Jacoby

By: King’s College London From: medicalxpress.com Scientists have identified immune cell types that could be targeted to develop specific immunotherapies in chemotherapy-resistant breast cancers. Researchers from King’s College London and The Institute of Cancer Research, London, with support from Breast Cancer Now, have performed a deep dive into the different immune markers within tumor tissues and blood samples of early …

View Post

Fertility drugs do not increase breast cancer risk, study finds

In In The News by Barbara Jacoby

Source: King’s College London From: eurekalert.org Drugs routinely used during fertility treatments to release eggs do not increase the risk of developing breast cancer, new research has shown. Researchers from King’s College London, in partnership with King’s Fertility, analysed studies involving 1.8 million women undergoing fertility treatments. These women were followed up in studies for an average period of 27 …